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A monoclonal antibody (mAb) that binds to a transient
intermediate may act as a catalyst for the corresponding reaction;
here we show this principle can extend on a macro molecular
scale to the induction of mutant-like oligomerization in a wild-
type protein. Using the common pathogenic E342K (Z) variant
of α1-antitrypsin as antigen – whose native state is susceptible
to the formation of a proto-oligomeric intermediate – we have
produced a mAb (5E3) that increases the rate of oligomerization
of the wild-type (M) variant. Employing ELISA, gel shift, thermal
stability and FRET time-course experiments, we show that mAb5E3
does not bind to the native state of α1-antitrypsin, but recognizes
a cryptic epitope in the vicinity of the post-helix A loop and
strand 4C that is revealed upon transition to the polymerization
intermediate, and which persists in the ensuing oligomer. This
epitope is not shared by loop-inserted monomeric conformations.
We show the increased amenity to polymerization by either the
pathogenic E342K mutation or the binding of mAb5E3 occurs
without affecting the energetic barrier to polymerization. As
mAb5E3 also does not alter the relative stability of the monomer
to intermediate, it acts in a manner similar to the E342K mutant,
by facilitating the conformational interchange between these two
states.
Key words: aggregation, antibody, α1-antitrypsin, polymerization,
protein stability.
INTRODUCTION
α1-Antitrypsin (SERPINA1) is an acute-phase glycoprotein,
secreted by hepatocytes and abundant in the plasma. A member
of the serpin superfamily, the primary role of α1-antitrypsin
is the inactivation of neutrophil elastase in the lung. The
pathophysiological importance of this protein is underscored
by individuals harbouring loss-of-function mutations, who have
a pre-disposition to emphysema [1], and those who exhibit a
gain-of-function phenotype: the formation of recalcitrant protein
deposits in the endoplasmic reticulum (ER) of the cell of synthesis.
These inclusions atypically fail to induce the ER unfolded protein
response [2,3], but cause distension of the organelle, interfere
with protein diffusion [4] and can lead to liver cirrhosis [5].
Currently, the only commonly practised clinical interventions are
replacement therapy, which is both costly and controversial as to
its efficacy [6], and liver transplantation, where end-stage liver
disease has ensued [5].
The most common pathological variant associated with α1-
antitrypsin deficiency is the Z allele (E342K), which is present
in ∼4% of Northern Europeans. This mutation has been
shown to facilitate the transition between the native state and a
conformation that is prone to the formation of ordered aggregates,
termed polymers [7]. Biophysical approaches have indicated
that polymer formation proceeds from monomer through several
unimolecular ‘activation’ steps [8,9]. The pathway culminates
in a bimolecular association that, being essentially irreversible,
renders the process under kinetic control [10]. Polymers isolated
from patients homozygous for the Z allelle have an unbranched
beads-on-a-string morphology [11,12], and several hypotheses as
to the underlying inter-molecular linkage have been advanced
based on biophysical [11–14] and crystallographic [15] evidence.
Chief among these are the A-sheet model [11], the β-hairpin
model [14] and the C-terminal model [15]. Although it remains
to be demonstrated which of these polymer states reflects those
present in patient populations, these disparate proposals suggest
that under certain conditions α1-antitrypsin can access multiple
end-point polymer states. Nevertheless, the inherent stability and
size heterogeneity of the final polymer form renders it a non-ideal
target for therapeutic interventions to mitigate the intra-hepatic
formation or deposition of polymers. Instead, manipulation of
the polymerization pathway itself represents a more tractable
approach [16]. However, a detailed molecular understanding of
this pathway requires tools for probing its intermediates.
Many examples exist of antibodies and related molecules
that exhibit conformation-specific recognition of targets such
as transthyretin [17], superoxide dismutase [18] and serpins,
including plasminogen activator inhibitor-1 [19] and α1-
antitrypsin [20]. In addition, some antibodies are known to alter
the behaviour of their cognate antigen, such as stabilizing against
[21] and inducing [22] conformational change. From a screen
developed to identify monoclonal antibodies (mAbs) that alter
the rate of polymerization of α1-antitrypsin, we identified one,
mAb5E3, that demonstrated both conformational specificity and
antigen-altering activity. This molecule was found to recognize
a cryptic epitope revealed in the transition to a polymerization
Abbreviations: AF488, Alexa Fluor 488 dye; AF594, Alexa Fluor 594 dye; AT, α1-antitrypsin; ER, endoplasmic reticulum; H/D exchange, hydrogen/
deuterium exchange; HRP, horseradish peroxidase; mAb, monoclonal antibody; PBS, phosphate-buffered saline.
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intermediate, and that persists in the ensuing polymer. Both
the pathogenic E342K variant purified from patient plasma,
and the wild-type M variant in the presence of the mAb,
showed a similar polymerization activation energy to wild-
type protein alone. Thus, this mAb increases conformational
flux between native and activated forms without affecting their
relative thermodynamic stabilities and without interfering with
subsequent oligomerization. These data show that an antibody
raised against an unstable mutant can act as a molecular template
to induce aberrant behaviour in a wild-type protein.
EXPERIMENTAL
Preparation of α1-antitrypsin
M (ATWT) and Z (ATE342K) α1-antitrypsin were isolated from
plasma of PI*MM and PI*ZZ α1-antitrypsin homozygotes
as detailed previously [12]. Control ATWT or ATE342K heat-
induced polymers were prepared by heating the monomeric
protein (0.2 mg · ml− 1) at 60 ◦C in phosphate-buffered saline
(PBS) (pH 7.4) for 3 h, and confirmed by non-denaturing
PAGE. Denaturant-induced polymers were generated using 3M
guanidinium chloride in PBS for 48 h at room temperature.
Variants of recombinant α1-antitrypsin were generated by site-
directed mutagenesis, expressed in Escherichia coli XL-1
Blue, and purified to homogeneity by affinity chromatography
using nickel-nitrilotriacetate (NTA)–S sepharose (Qiagen) and Q
Sepharose (GE Healthcare Life Sciences) as detailed previously
[9,10]. Fab fragments were generated using a commercial papain-
based kit according to the manufacturers’ instructions (Thermo
Scientific).
Production and screening of antibodies that alter polymerization
of ATE342K
Balb/c mice were immunized with monomeric ATE342K, and
spleen cells were harvested and fused with myeloma cells. The
supernatants of the resulting hybridoma clones were screened first
by antigen-mediated ELISA using purified ATE342K monomer as
the antigen; those of selected clones were then heated at 45 ◦C for
45 h in the presence of 20 μg · ml− 1 ATE342K, and the consequent
polymers were quantified using an ELISA with the polymer-
specific antibody mAb2C1 and a non-conformation sensitive
antibody, mAb9C5 [20]. To verify whether identified antibodies
were interfering with the assay itself, a competitive ELISA was
performed in which the plate was coated with polymer-specific
mAb2C1, loaded with excess polymer antigen, and different
dilutions of cell culture supernatants were applied. Detection was
by horseradish peroxidase (HRP)-conjugated mAb9C5. The clone
showing increased polymerization levels with respect to a media-
only control was sub-cloned by limited dilution, expanded as
a cell line, and characterized by antigen-mediated, competitive,
polyclonal sandwich and monoclonal sandwich ELISA.
Antigen and sandwich ELISA
The protocols used have been described previously [20]. Plates
were coated overnight with antigen-purified rabbit polyclonal
anti-α1-antitrypsin antibody at 2 μg · ml− 1 in PBS for sandwich
ELISA, or purified ATE342K in PBS for antigen-mediated ELISA.
Following this they were washed with 0.9% (w/v) sodium
chloride and 0.05% (v/v) Tween 20 and blocked for 2 h with
300 μl per well of blocking buffer (PBS, 0.25% BSA, 0.05%
Tween 20 and 0.025% sodium azide). For sandwich ELISA,
samples were diluted in blocking buffer to a final volume of
50 μl, added to the plate and incubated for 2 h. After washing,
for both types of ELISA the wells were incubated for 2 h
with the primary mAbs (mAb5E3 or polymer-specific mAb2C1)
at a concentration of 1 μg · ml− 1 diluted in blocking buffer, the
wells were washed again and rabbit anti-mouse HRP-conjugated
antibody (Sigma) was added for 1 h. After removing residual
secondary antibody, the reaction was developed for 10 min with
3,3′,5,5′-tetramethylbenzidine (TMB) substrate solution (Sigma–
Aldrich), stopped with 1 M H2SO4, and an endpoint measurement
of HRP activity at 450 nm was made using a SpectraMax M2
plate reader (Molecular Devices). All steps were performed at
room temperature.
Native thermal stability assays
Experiments, using the SYPRO Orange fluorescent reporter (Life
Technologies) were performed as detailed previously [10], and
the temperature midpoint was determined by application of an
equation describing thermal denaturation to the data [23,24]:
FT = FN + mN (T − Tm) + (FI + m I (T − Tm)) e
C( 1Tm − 1T )
1 + eC( 1Tm − 1T )
where FT is the fluorescence at temperature T , Tm is the transition
midpoint temperature, FN and FI are the fluorescence of the native
and intermediate states, mN and mI describe their temperature
dependence around temperature Tm, and C =Hm/R, the enthalpy
of unfolding at Tm divided by the gas constant. As the reaction is
not at equilibrium [10] the optimized value of Hm was not used.
Thiol labelling of plasma α1-antitrypsin
α1-Antitrypsin has a single endogenous surface-exposed cysteine
residue (Cys232) that is readily conjugated with thiol-reactive
probes [8,25]. Variants of α1-antitrypsin were reduced using
20 mM β-mercaptoethanol, buffer exchanged into PBS, and
incubated with a 10-fold molar excess of Alexa Fluor 488
(AF488) maleimide or Alexa Fluor 594 (AF594) maleimide (Life
Technologies) overnight at 4 ◦C with reaction quenching using
5 mM cysteine. Application to, and elution from, a 1 ml HiTrap
Q Sepharose column was used to remove remaining free label.
FRET-based polymerization assays
α1-Antitrypsin, labelled with fluorophores at residue Cys232, was
diluted to 0.1 mg · ml− 1 in PBS in the presence and absence
of 0.45 mg · ml− 1 antibody and a final volume of 10 μl.
Polymerization was reported by an increase over time in FRET
between the AF488 donor dye (excitation at 470 nm) and the
AF594 acceptor dye (emission recorded at 605 +− 15 nm) upon
heating in a Realplex4 quantitative PCR instrument (Eppendorf).
The Fo¨rster radius of this pair is ∼60 Å (1 Å = 0.1 nm) [26], which
makes them useful at distances predicted by the different models
of polymerization to arise between monomers in a repeating
polymer [14,15,25,27,28]. The increase in FRET signal was found
to be satisfactorily fitted by a single or double sigmoidal curve in
Prism (GraphPad):
Ft = H × t 2 ×
(
w(
t 20.5,1 + t 2
) + (1 − w)(
t 20.5,2 + t 2
)
)
+ L
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Figure 1 Screens for mAbs that alter polymerization, and the specificity of mAb5E3
(A) Cell culture supernatants of hybridoma clones including 5E3 (black bar) were incubated at 45◦C for 45 h with ATE342K at 20 μg · ml− 1, and polymer levels were quantified by sandwich ELISA
using plates coated with the polymer-specific mAb2C1 and detection by mAb9C5 conjugated to HRP. Values shown are fold-increases in polymer levels with respect to a media-only control (shaded bar).
(B) A sandwich ELISA performed using plates coated with anti-α1-antitrypsin polyclonal antibody, bound for 2 h with serially diluted conformers of ATWT, and detection by mAb5E3 at 1 μg · ml− 1 and
an HRP-conjugated secondary antibody. After baseline subtraction the data at different dilutions were fitted to a four-parameter logistic function and the values at a total antigen load of 2.5 ng recorded
(mean+−S.E.M. for four independent experiments). A one-way ANOVA using Bonferroni’s correction indicated a significant difference between polymers and monomers (*P < 0.05; **P < 0.01). (C)
Gel shift experiment using AF488/AF594-labelled ATWT protein separated by 3–12 % (w/v) non-denaturing PAGE: ‘M’, unheated monomer; ‘P’, monomer heated at 53◦C for 12 h; ‘P + ab’, the
same heated monomer mixed with a 1.5-fold molar excess of mAb5E3 5 min prior to electrophoresis; and ‘ab + P’, monomer incubated for 5 min with mAb5E3 prior to heating at 53◦C for 12 h.
Detection was by fluorescence using a UV transilluminator. The upper panel has deliberately been overexposed (‘sat ’) to highlight the oligomeric region of the gel; the lower panel shows the affected
monomer region at a lower intensity (‘u/s’). The asterisk indicates a species with a migration intermediate between monomer and dimer that appears to represent a polymerization intermediate [33].
(D) Purified ATE342K was incubated at 20 μg · ml− 1 for 45 h at 45◦C in the presence of 0–50 μg · ml− 1 mAb5E3 and the resulting polymers were quantified by silver-stained non-denaturing PAGE.
(E) Combined data from mAb2C1 ELISA following incubation of 20 μg · ml− 1 or 100 μg · ml− 1 ATE342K for 45 h at 45◦C with a 0–1.33-fold molar ratio of mAb5E3. The resulting absorbance readings
from each of three experiments were normalized to lie between 0 and 1, and the abscissa shows the molar ratio of mAb5E3 to α1-antitrypsin concentration. The curve reflects a four-parameter logistic
equation; a half-maximal effect was observed at a molar stoichiometry of 0.23 +− 0.03.
where Ft is the fluorescence at time t, H is the dynamic range of the
curve, L is the baseline, w is the fraction contribution to the signal
by the curve with a half-time of t0.5,1 and (1 − w) is the fraction
contribution to the signal by the curve with a half-time of t0.5,2.
This equation permitted numerical calculation by the software of
the overall time to half-maximal fluorescence intensity.
Gel-based experiments
Bis-Tris non-denaturing PAGE (3–12% (w/v) acrylamide) (Life
Technologies) was used to determine the oligomeric state of α1-
antitrypsin and perform gel shift experiments, with 2–4 μg of
protein per lane for staining with Coomassie Blue and 0.05–
2 μg for fluorescence detection using a UV transilluminator.
This gel system was also used for mobility shift experiments;
antibodies cause a decreased rate of α1-antitrypsin migration due
both to the increased size of the antibody–antigen complex and
an elevated overall isoelectric point. Densitometry was performed
using ImageJ [29].
RESULTS
Identification of a monoclonal antibody that increases the rate of
polymerization
We set out to identify, from a panel of mAbs raised against
an oligomerization-prone variant of α1-antitrypsin, one that
could accelerate polymerization, and determine whether it could
induce comparable behaviour in the wild-type protein. Standard
protocols were followed to identify hybridomas expressing
mouse monoclonal antibodies against purified Z α1-antitrypsin
(ATE342K) [20,30]. Aliquots of cell culture supernatant from these
hybridomas were mixed with ATE342K, heated at 45 ◦C for 45 h,
and polymer levels were quantified by a sandwich ELISA using
plates coated with the polymer-specific mAb2C1 and detection
of bound polymers with conformation-insensitive mAb9C5–HRP
[20]. One clone, 5E3, increased the level of polymer ∼4-fold with
respect to a media-only control (Figure 1A), and the effect was
confirmed using purified antibody in a sandwich ELISA (Sup-
plementary Figure S1A) and interference assay (Supplementary
c© 2015 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Licence (CC-BY) (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted
use, distribution and reproduction in any medium, provided the original work is properly cited.
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Figure 2 Effect of mAb5E3 on the transition to a polymerization intermediate
(A) A representative SYPRO Orange thermal shift experiment using 0.1 mg · ml− 1 ATE342K in
the presence (medium grey) and absence (light grey) of a 1.5-fold molar excess of mAb5E3
(black). Samples were heated from 25◦C to 95◦C at a rate of 1◦C · min− 1. The fluorescence
of SYPRO Orange with α1-antitrypsin reports transition to a polymerization intermediate [10].
Transition midpoints were inferred for each protein by non-linear regression, shown as a white
overlaid dashed line, as described in the text. (B) Thermal midpoints of denaturation were
calculated for 0.1 mg · ml− 1 ATWT, ATE342K and a 1.5-fold molar concentration of mAb5E3 alone
or in combination. Data were fitted by a single or double two-state unfolding equation, used
to de-convolute the contribution from mAb5E3 (grey) and α1-antitrypsin (black) components.
The temperature gradient was 1◦C · min− 1. Error bars reflect +−SEM of at least four individual
experiments.
Figure S1B). Subsequent experiments made use of purified
mAb5E3.
mAb5E3 shows specificity for heat- and denaturant-induced
polymers
Polymerization is a kinetically controlled process, and comprises
at least one unimolecular activation step and a bimolecular
association step [9]:
M ↔ M∗
M∗ + M∗ → P
The consequence of this scheme is that the reaction does
not reach equilibrium; there is a positive flux of monomer
incorporated into oligomers in a manner influenced by protein
concentration and the activation energy barrier to oligomer
formation. Consequently, an increased polymerization rate could
be achieved through changes in thermodynamic stability of
different components of the pathway or a reduction in energy
required to transition from one state to the next [7]. Thus, any
conformational selectivity could play a role in the apparent
polymerization-enhancing activity of mAb5E3.
Experiments were performed to characterize any preferential
binding of mAb5E3 to different conformations of α1-antitrypsin. A
Western blot of heated ATE342K samples indicated that mAb5E3 is
able to recognize heat-induced polymer (Supplementary Figure
S1C). However, it is unlikely that binding to the terminal polymer
form would increase the rate of polymerization, as this form is
itself extremely stable [11,31] with at best marginal dissociation
reported [32]. Recognition of different monomer conformations
and heat- and guanidium chloride-induced polymers were
compared by ELISA (Figure 1B). The three main proposed
models for the structure of the pathological polymer countenance
a monomeric unit that is in a loop-inserted conformation,
consistent to varying degrees with the cleaved and latent states of
the protein. However, these results revealed a distinct preference
for polymer over monomer, and in contrast with mAb2C1 [20], no
clear selectivity between denaturant- and heat-induced polymer
forms.
Monoclonal antibodies migrate more slowly in non-denaturing
gels than α1-antitrypsin due to their larger size and higher
isoelectric point. We exploited this in performing a gel shift
experiment using ATWT that had been fluorescently labelled at
Cys232 with AF488 and AF594 dyes (Figure 1C). M α1-antitrypsin
(ATWT) was polymerized at 53 ◦C for 12 h, either in the presence
of a 1.5-fold molar excess of mAb5E3 (lane 4) or alone (lane
2) and pre-made polymers were also mixed with the same
proportion of antibody 5 min prior to electrophoresis by non-
denaturing PAGE (lane 3). A comparison of lanes 2 and 3 of
the gel revealed sequestration of the oligomeric material by the
antibody into a slower-migrating species, without a reduction in
intensity of the monomer band. Interestingly, a band interposed
between monomer and dimer was also bound by the antibody;
such a species has been identified previously as a hallmark of
the polymerization intermediate [33]. ATWT polymerized in the
presence of mAb5E3 demonstrated an increased quantity of higher-
order material and a corresponding decrease in the amount of
monomer left at the end of the incubation, providing a secondary
confirmation of the polymerization-enhancing activity.
mAb5E3 increases polymerization in a dose-dependent manner
The experiments in Figures 1(B) and 1(C) indicate that mAb5E3
is able to form a stable complex with polymer and possibly an
intermediate species as well. If a stable interaction is the basis of
its activity, then the antibody would be expected to act in a dose-
dependent fashion at a comparable range of concentrations to
α1-antitrypsin. A contrasting scenario would be one in which the
antibody acts as a catalyst by transiently binding and stabilizing
a transition state on the polymerization pathway, which could
occur at markedly lower molar ratios. Aliquots of ATE342K were
incubated with different concentrations of mAb5E3 at 45 ◦C for
45 h, and the presence of polymers was identified by non-
denaturing PAGE (Figure 1D) and quantified by ELISA using
mAb2C1 (Figure 1E). Both techniques were found to report a dose-
dependent increase in polymers at higher mAb5E3 concentrations
with respect to the control, with the latter data fitted to a four-
parameter logistic equation yielding an EC50 value of 0.23 +− 0.03.
As IgG are divalent, this is equivalent to a binding-site ratio of
c© 2015 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Licence (CC-BY) (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted
use, distribution and reproduction in any medium, provided the original work is properly cited.
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Figure 3 mAb5E3 increases the rate of α1-antitrypsin polymerization
(A) Left panel: an equimolar population of ATWT labelled either with a donor (AF488) fluorophore or an acceptor (AF594) fluorophore was incubated at 0.1 mg · ml− 1, and polymerization was
monitored as an increase in FRET. Curves representing samples incubated at different temperatures in the presence (grey lines) and absence (black lines) of 0.45 mg · ml− 1 mAb5E3 are shown.
Overlaid dashed lines (black and white, respectively) show the curves of best fit. Right panel: 0.1 mg · ml− 1 ATWT labelled with AF488 and AF594 maleimide heated at various temperatures for 12 h
in the absence and presence of a 1.5-fold molar ratio of mAb5E3, separated by non-denaturing PAGE and visualized using a UV transilluminator. The upper panel has been overexposed (‘sat ’) and
the lower panel shows the affected monomer region at a lower intensity (‘u/s’). (B) Left panel: an Arrhenius analysis of polymerization half-times as determined from FRET-based progress curve
recorded at temperatures of 50–60◦C for 0.1 mg · ml− 1 ATWT (black, unbroken lines, circles), ATE342K (medium grey, dashed lines, diamonds) and ATR (light grey, dotted lines, squares) in the
presence (shaded symbols) or absence (open symbols) of a 1.5-fold molar concentration of mAb5E3. The data arise from at least four independent experiments and are means +− S.D. of two or more
observations at a given temperature. Right panel: the apparent activation energy (mean+−S.E.M.) for the polymerization of α1-antitrypsin was calculated from the slopes of linear regressions. There
was no significant difference between the different forms of α1-antitrypsin in the presence and absence of mAb5E3, with values of ∼300 kJ · mol− 1.
0.46:1 required to achieve a half-maximal effect. Thus, mAb5E3
most likely operates by binding in a near-stoichiometric fashion to
a component of the polymerization pathway following activation
of the monomer species.
mAb5E3 has no effect on the equilibrium between native
and intermediate forms
Thermal shift experiments using SYPRO Orange report the
transition from the α1-antitrypsin native state to a pre-polymer
intermediate [10], and thus should indicate whether the antibody
plays an active role in this process. From normalized thermograms
(Figure 2A), it was possible to obtain thermal midpoint
temperatures (Tm) of the individual components alone or in
combination by non-linear regression of a double two-state
unfolding equation (Figure 2B). It was observed that the presence
of the antibody had a negligible effect on the transition midpoint
of α1-antitrypsin, but a slight stabilization (by 1.7 +− 0.3 ◦C) of the
antibody. As mAb5E3 unfolding occurs at a higher temperature than
the conversion of α1-antitrypsin to intermediate, this is probably
to be the result of stabilization due to complex formation either
with the intermediate or a later-stage species such as polymer.
Progress curves report a mAb5E3-induced increased rate
of polymerization
ATWT was labelled via the endogenous cysteine residue at position
232 with AF488 maleimide and AF594 maleimide dyes. Despite
stark differences, the various polymer models broadly agree that
fluorophores of adjacent monomers would be brought within a
distance of less than 80 Å in the polymer chain [8,14,15,27,28].
Thus, temperature-induced polymerization could be monitored
based on the increase in FRET between this pair of probes –
whose Fo¨rster radius is 60 Å [26] – with excitation of AF488
c© 2015 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Licence (CC-BY) (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted
use, distribution and reproduction in any medium, provided the original work is properly cited.
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Table 1 Polymerization of α1-antitrypsin variants in the presence and
absence of mAb5E3
A summary of the data in Figure 3(B), showing the times taken to reach a half-maximal
polymerization FRET signal at 53◦C, and the calculated apparent activation energy of the
reaction (E act). Results are means +− S.E.M.
Sample t 0.5 at 53◦C (s) E act (kJ · mol− 1)
ATWT 37.8(+−2.3) × 103 292 +− 17
ATWT + mAb5E3 4.9(+−0.3) × 103 316 +− 26
ATE342K 10.7(+−0.7) × 103 314 +− 17
ATE342K + mAb5E3 3.8(+−0.1) × 103 301 +− 11
ATR 3.3(+−0.2) × 103 287 +− 20
ATR + mAb5E3 2.2(+−0.1) × 103 293 +− 17
at 470 nm and emission recorded from AF594 at 605 nm
(+−15 nm). Figure 3(A, left panel) shows progress curves recorded
for ATWT at temperatures between 50.2 ◦C and 56.8 ◦C. A clear
stimulatory effect was seen in the presence of the antibody, even
at temperatures otherwise with no detectable polymerization,
highlighted by a non-denaturing gel (Figure 3A, right panel),
which showed at the conclusion of the experiment a depleted
monomer and substantial amount of sequestered polymer in the
presence of mAb5E3 with respect to antibody-free controls. This
acceleration was not due simply to a template mechanism by
the antibody, as in dose–response experiments characteristics of
the FRET curves were found to be monophasic with respect to
concentration, rather than bell-shaped (Supplementary Figures
S1D–S1E).
mAb5E3 does not affect the polymerization activation energy
In the typical range of temperatures used to induce
polymerization, the rate at which α1-antitrypsin polymers form
shows an Arrhenius-type temperature dependence [9,10]. ATE342K
and recombinant wild-type (ATR) were fluorescently labelled in
the same manner as ATWT. Both have an inherently increased
rate of polymerization with respect to the wild-type protein:
ATE342K has a decreased kinetic stability against conversion to the
polymerization intermediate [7], whereas, due to expression in E.
coli, ATR lacks the three glycan chains present in plasma-derived
material (on aparagine residues at positions 46, 83 and 247), which
are associated with maintaining a compact monomeric state [34].
Half-times of polymerization were derived using an empirical
sigmoidal, or double-sigmoidal, function from FRET progress
curves of ATWT, ATE342K and ATR in the presence and absence
of mAb5E3 at temperatures between 50 ◦C and 60 ◦C (Figure 3B,
left panel). Consistent with its well-characterized tendency to
form polymers, polymerization half-times for ATE342K alone were
lower than for ATWT. The rate of polymerization of both variants
was substantially increased in the presence of mAb5E3, such that
the two became almost equivalent in behaviour, as seen in the
strikingly similar regression lines. Thus, despite the intrinsic
kinetic instability of ATE342K [7], mAb5E3 caused a convergence
of the response of both variants to thermal challenge. Notably,
the rates for the glycosylated plasma proteins in the presence
of antibody are comparable to ATR (expressed in E. coli and
therefore non-glycosylated) without antibody. The presence of
mAb5E3 caused a detectable, but less pronounced, acceleration of
ATR polymerization.
Apparent activation energy (Eact,app) values were calculated
from the linear regressions (Table 1). At ∼300 kJ · mol− 1 –
consistent with previous calculations for wild-type recombinant
α1-antitrypsin [10] – no significant difference was observed
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Figure 4 Increased rate of α1-antitrypsin polymerization in the presence of
Fab5E3
(A) Representative FRET-based progress curves showing the polymerization of ATWT in the
presence (grey lines) and absence (black lines) of a 1.5-fold concentration of Fab5E3. (B)
Calculated polymerization half-times (means +− S.E.M.) at a reference temperature, 53◦C, from
at least nine independent data points.
between ATE342K, ATWT or ATR either in the presence or in the
absence of antibody (Figure 3B, right panel). This analysis shows
that neither the Z mutation, or the absence of glycan chains from
asparagine residues at positions 46, 83 and 247, nor the presence
of mAb5E3 affects the overall energetic barrier to polymerization.
A monovalent Fab fragment increases the rate of polymerization
of ATWT
To determine the extent to which divalent binding by mAb5E3
contributes to the observed polymerization rates, Fab5E3 fragments
were generated by digestion with papain and tested on ATWT in
FRET-based time-course experiments. As with the full antibody,
the induction of polymerization at an otherwise non-favoured
temperature was observed (Figure 4A). To quantify this effect, a
comparison was made between the half-times of polymerization
at a reference temperature (Figure 4B). It was found that the
presence of Fab5E3 induced a similar rate of polymerization in
ATWT to that of ATE342K, with a half-time of 13.5(+−0.4)×103 s
at 53 ◦C. Thus, binding of the mAb5E3 epitope by a monovalent
ligand resulted in behaviour comparable to that of the antigen
against which the antibody had been raised.
c© 2015 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Licence (CC-BY) (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted
use, distribution and reproduction in any medium, provided the original work is properly cited.
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(A) A molecular surface representation of loop-inserted α1-antitrypsin (PDB accession 1EZX, chain A), used to approximate the parsimonious conformation of the monomer proposed by the three
main models for the terminal polymer [10], with β-sheet A oriented along the Z plane. Peptide fragments associated with transition to a heat- or denaturant-induced polymerization intermediate were
identified by reconciling three previous studies [35–37] as described in the text. (B) Left panel: several surface-exposed residues that were situated on the face of α1-antitrypsin primarily implicated
in intermediate formation were mutated to arginine to explore possible involvement in the mAb5E3 cryptic epitope. Recombinant protein was heated at 54◦C for 30 min in the presence and absence of
mAb5E3 and residual monomer was quantified using densitometry of non-denaturing PAGE gels (a representative gel is shown in the bottom panel). Results are mean+−S.E.M. proportions of residual
monomer for each variant in the presence of mAb5E3 relative to its absence, calculated from four independent experiments. Right panel: mutations that reduced the effect of mAb5E3 on polymerization
are shown on a schematic representation of loop-inserted α1-antitrypsin. Structure figures were prepared using PyMOL (http://www.pymol.org).
The mAb5E3 epitope is in the vicinity of residues Ser47 and Glu205
Although polymers induced by heat share a conformational
epitope with ex vivo material that denaturant-induced polymers
do not [33], mAb5E3 is able to recognize both forms (Figure 1B).
On this basis, an attempt was made to reconcile regions of α1-
antitrypsin implicated by three previous studies in the transition
to intermediate, but that do not change in the transition from
intermediate to polymer, based on observations in the literature.
Peptide fragments were shortlisted that (a) were among nine
exhibiting the greatest difference in hydrogen/deuterium (H/D)
exchange between native and intermediate states [35]; (b) were
also among nine fragments having the least difference in H/D
exchange between intermediate and polymer [35]; and (c) also
spanned at least one residue identified by NMR [36] or surface
accessibility experiments [37]. The resulting surface map of α1-
antitrypsin revealed a starkly polarized molecule (Figure 5A).
From this analysis, several initial sites were selected for arginine
scanning mutagenesis. Six mutants were expressed in E. coli
(C232S, S47R, E205R, V216R, S292R and T392R) and purified
to homogeneity. Gel-based quantification of recombinant polymer
is usually inferred from the loss of monomer following non-
denaturing PAGE [38]. These mutants were subjected to a 30-min
incubation at 54 ◦C, expected from the ATR polymerization data
in Figure 3(B) to yield roughly a 50% depletion of monomer
in the presence of mAb5E3. The relative amount of residual
monomer in the absence and presence of mAb5E3 was quantified
by non-denaturing PAGE and densitometry in four experiments
c© 2015 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Licence (CC-BY) (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted
use, distribution and reproduction in any medium, provided the original work is properly cited.
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(A) A stability-polymerization analysis [10] which compares the average difference in T m to the change in the natural logarithm of polymerization half-time. The α1-antitrypsin consensus curve
determined in that paper is shown as an unbroken line, flanked by dashed lines which represent a 2-fold greater or lesser rate of polymerization than predicted from effects on native state stability
alone. Upon binding to mAb5E3, the rate of polymerization increases in a manner that is not accounted for by changes in native state stability for ATWT or ATE342K (circles). (B) Notional energy landscape
in which the presence of mAb5E3 facilitates interchange via a stabilized transition state between the native (M) and intermediate (M*) forms, without affecting the stability of either the intermediate or
the oligomerization transition state that yields polymer (P).
(Figure 5B, left and bottom panels). Both the S47R or E205R
mutants, on the post-helix A loop and strand 4C, respectively,
showed relative insensitivity to the presence of mAb5E3 under these
conditions, suggesting that they are components of the epitope
(Figure 5B, right panel).
DISCUSSION
Effector molecules can be used as tools to probe conformational
transitions and thereby provide a means to understand molecular
mechanism [21]. In the present study, we have characterized
a mAb that increases the rate of polymerization in a dose-
dependent manner (Figure 1E), shows a strong preference for
polymer over the non-activated monomer (Figures 1B and 1C),
does not affect native state stability against change to an activated
intermediate (Figure 2B), and does not preferentially act on the
barrier between activated monomer and polymer (Figure 3B).
However, a stability-polymerization analysis [10] shows that the
effect on the polymerization rate for both ATWT and ATE342K
variants is greater than expected from negligible effects on
native state stability (Figure 6A). Additionally, the antibody
interacts with a species that is a hallmark of a polymerization
intermediate (Figure 1C), induces polymerization at otherwise
non-polymerization-permissive temperatures (Figures 3A and
4A) and increases the rate of polymerization of both the
endogenously glycosylated M and Z variants of α1-antitrypsin
to a level comparable to that of non-glycosylated recombinant
protein (Figure 3B). Monovalent interaction by the Fab fragment
induces the wild-type variant to behave like that of the Z variant
alone (Figure 4B).
With an epitope that appears to include Ser47 and Glu205
(Figure 5B), this antibody bridges two important regions of α1-
antitrypsin: Ser47 lies adjacent to the Asn46 glycosylation site,
and Glu205 is proximate to Thr203, which forms an interaction
with Glu342, the site of the Z mutation. Given the unexpected
coincidence of mAb5E3-treated endogenously glycosylated plasma
protein with the temperature-dependent rate of polymerization of
non-glycosylated recombinant material, it is noteworthy that the
Asn46 glycosylation site is also implicated in significant effects
on altered H/D exchange in the vicinity of Glu205 [34].
Collectively, these data are consistent with a mechanism in
which mAb5E3 acts in two distinct ways: (a) a stabilization of
conformational changes that occur in the Ser47/Glu205 region
during transition between the native state and the polymerization
intermediate through interaction with a cryptic epitope; and (b)
in the context of the full antibody, an increase in the efficiency
of the bimolecular association step by optimally orienting the
molecules in a manner that reduces the proportion of non-
productive interactions resulting from interference by the glycan
chains. The latter characteristic is reflected by a lack of templating
mechanism and changes in rates of, but not the energetic barrier
to, polymerization.
Polymerization is a process that is under kinetic, not
thermodynamic, control [10]. Thus, the basis of the susceptibility
of the Z variant to polymerization is an increased rate of
interchange between – but not the relative stability of – native
and activated states [7]. In the context of the subsequent,
essentially irreversible, oligomerization step, this increased flux
translates overall into an enhanced rate of polymerization. The
conformation-stabilizing effect of mAb5E3 bears these hallmark
characteristics. A mechanism consistent with the cumulative data
from the present study is shown in Figure 6(B), in which mAb5E3
binds in a reversible fashion to a cryptic epitope that is revealed
in the transition state during activation to intermediate, increasing
its stability and accordingly reducing the unimolecular activation
energy barrier. Against a kinetic backdrop, as with the Z variant,
the resulting increased flux translates into an acceleration of the
overall polymerization process. In effect, the antibody causes the
wild-type M variant to adopt the behaviour of the pathogenic Z
mutant.
From this, a number of observations can be made about the
polymerization process of α1-antitrypsin. The data are consistent
with a model in which the presence of glycan chains slow the
inter-conversion between native and intermediate conformers,
such that mAb5E3 exerts a greater effect on glycosylated
material. Glycans also increase the proportion of ‘frustrated’
bimolecular interactions, without affecting the energy barrier
c© 2015 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Licence (CC-BY) (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted
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to polymerization. In addition, the activated state of the Z
variant shows a similar amenity to polymerization to that of
the wild-type protein, indicating that there are no substantial
structural differences induced by the E342K mutation once in this
intermediate conformation. Finally, it is of note that the binding of
mAb5E3 to the intermediate fails to interfere with oligomerization;
this indicates that there are structural changes associated with the
cryptic epitope that persist from activated monomer to polymer.
In conclusion, we have shown how an antibody raised against
a kinetically unstable mutant can induce similar behaviour in
the wild-type protein. This monoclonal antibody represents a
tool that can be used in further studies to probe the effects of
novel mutations and effector molecules on the polymerization
intermediate and, in particular, oligomerization.
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